These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15160825)

  • 1. Outcomes-based drug coverage in British Columbia.
    Morgan S; Bassett K; Mintzes B
    Health Aff (Millwood); 2004; 23(3):269-76. PubMed ID: 15160825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An outcomes-based approach to decisions about drug coverage policies in British Columbia.
    Morgan S; Bassett K; Mintzes B
    Psychiatr Serv; 2004 Nov; 55(11):1230-2. PubMed ID: 15534010
    [No Abstract]   [Full Text] [Related]  

  • 3. The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Barer M; Reid RJ
    Health Policy; 2011 Jul; 101(2):185-94. PubMed ID: 21255859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative.
    Paterson JM; Laupacis A; Bassett K; Anderson GM;
    Health Aff (Millwood); 2006; 25(5):1436-43. PubMed ID: 16966744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents.
    Schneeweiss S; Dormuth C; Grootendorst P; Soumerai SB; Maclure M
    Med Care; 2004 Jul; 42(7):653-60. PubMed ID: 15213490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using pharmacoeconomic analysis to make drug insurance coverage decisions.
    Anis AH; Rahman T; Schechter MT
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):119-26. PubMed ID: 10176146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. British Columbia poised to reduce drug coverage.
    Quandt T
    Can HIV AIDS Policy Law Rev; 2002 Mar; 6(3):38-9. PubMed ID: 14979239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 9. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.
    Schneeweiss S; Maclure M; Dormuth CR; Glynn RJ; Canning C; Avorn J
    Clin Pharmacol Ther; 2006 Apr; 79(4):379-88. PubMed ID: 16580906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.
    Morgan S; Cunningham C
    Healthc Policy; 2008 Feb; 3(3):e128-53. PubMed ID: 19305760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.
    Morgan S; Cunningham C
    Healthc Policy; 2008 Feb; 3(3):54-63. PubMed ID: 19305768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. British Columbia revamps process for determining drug coverage.
    Shuchman M
    CMAJ; 2011 Feb; 183(2):E79-80. PubMed ID: 21173059
    [No Abstract]   [Full Text] [Related]  

  • 13. Health services utilization with reference drug pricing of histamine(2) receptor antagonists in British Columbia elderly.
    Hazlet TK; Blough DK
    Med Care; 2002 Aug; 40(8):640-9. PubMed ID: 12187178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
    Hanley GE; Morgan S; Hurley J; van Doorslaer E
    Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-provincial use of cardiac services: the importance of data-sharing for clinical registries and outcomes research.
    Humphries KH; Carere RG; Izadnegahdar M; Galbraith PD; Knudtson ML; Ghali WA
    Can J Cardiol; 2005 Mar; 21(3):267-72. PubMed ID: 15776116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia.
    Grootendorst P; Stewart D
    Health Econ; 2006 Jul; 15(7):735-42. PubMed ID: 16498702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of income-based deductibles on drug use and health care utilization among older adults.
    Law MR; Cheng L; Worthington H; Mamdani M; McGrail KM; Chan FKI; Majumdar SR
    CMAJ; 2017 May; 189(19):E690-E696. PubMed ID: 28507088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whither seniors' pharmacare: lessons from (and for) Canada.
    Morgan SG; Barer ML; Agnew JD
    Health Aff (Millwood); 2003; 22(3):49-59. PubMed ID: 12757272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Did implementation of no-fault auto-insurance in British Columbia, Canada, impact return to work following road trauma? Protocol for a before-after survival analysis.
    Chan H; Erdelyi S; Jiang A; McLeod C; Koehoorn M; Brubacher JR
    BMJ Open; 2023 Sep; 13(9):e075858. PubMed ID: 37739458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.